Can Fluconazole and Metronidazole Be Given Together?
Yes, fluconazole and metronidazole can be safely co-administered together, as there are no documented drug-drug interactions between these medications, and this combination is clinically appropriate when treating mixed anaerobic-fungal infections. 1
Safety Profile of Co-Administration
- No pharmacokinetic interactions exist between metronidazole and fluconazole, as fluconazole's CYP450 interactions do not significantly affect metronidazole metabolism 1
- Fluconazole has been studied extensively for drug interactions with other medications, and while potential interactions are common in hospitalized patients (occurring in 70% of admissions), clinically significant adverse events from fluconazole drug interactions are rare 2
- Metronidazole is metabolized primarily by the liver to 5 metabolites and has low protein binding (<20%), making it less susceptible to displacement interactions 3
Clinical Scenarios Requiring Both Medications
Mixed anaerobic-fungal infections are the primary indication for combining these agents:
- In critically ill patients with intra-abdominal sepsis, both anaerobes and Candida species may be present, requiring metronidazole for anaerobic coverage and fluconazole for fungal coverage 1
- The IDSA recommends empiric antifungal therapy in critically ill patients with risk factors for invasive candidiasis, which frequently overlap with anaerobic infection risk factors 1
Dosing Recommendations When Using Both Agents
For mixed anaerobic-fungal infections:
- Start metronidazole 500 mg IV/PO every 8 hours for anaerobic coverage 1
- Add fluconazole 800 mg loading dose on Day 1, then 400 mg daily for empiric Candida coverage 4, 1
For sequential therapy (when candidiasis develops during metronidazole treatment):
- Add fluconazole 150 mg single dose for uncomplicated vulvovaginal candidiasis 1
- Use fluconazole 400 mg daily for more severe or invasive infections 1
High-Risk Populations Requiring Dual Coverage
Consider empiric coverage for both anaerobes and Candida in ICU patients with multiple risk factors including:
- Recent abdominal or bowel surgery 1
- Prolonged broad-spectrum antibiotic use 1
- Central venous catheters 1
- Parenteral nutrition 1
- Dialysis 4
Important Caveats
Pregnancy considerations:
- Metronidazole is acceptable for anaerobic infections in pregnant women 1
- Fluconazole should be used cautiously in pregnancy, with amphotericin B deoxycholate preferred for invasive candidiasis 1
Duration of therapy:
- Fluconazole should be continued for 14 days after the first negative blood culture for candidemia 1
- Metronidazole duration depends on the specific anaerobic infection being treated 3, 5
Monitoring: